Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|May 26, 1999
Influence of arteriovenous sampling on remifentanil pharmacokinetics and pharmacodynamicsD J Hermann, T D Egan, K T MuirHealth Bulletin|June 20, 2003
Care management in three practices--scope for improvement?B A Hamilton, W R Primrose, K T MuirBritish Journal of Pharmacology|August 1, 1979
The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammoniumH E Barber, T N Calvey, K T MuirJournal of Pharmacokinetics and Biopharmaceutics|April 1, 1981
Predicting individual phenytoin dosageS Vozeh, K T Muir, L B Sheiner, et al.British Journal of Anaesthesia|February 19, 2004
Remifentanil by bolus injection: a safety, pharmacokinetic, pharmacodynamic, and age effect investigation in human volunteersT D Egan, S E Kern, K T Muir, et al.British Journal of Pharmacology|January 1, 1976
The effect of edrophonium on erythrocyte acetylcholinesterase and neuromuscular function in the ratH E Barber, T N Calvey, K T Muir, et al.Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1989
The influence of assay variability on pharmacokinetic parameter estimationD A Graves, C S Locke, K T Muir, et al.Journal of Pharmaceutical Sciences|May 1, 1985
Estimation of theophylline clearance during intravenous aminophylline infusionsT M Gilman, K T Muir, R C Jung, et al.Clinical Pharmacology and Therapeutics|June 1, 1976
Plasma concentration of edrophonium in manT N Calvey, N E Williams, K T Muir, et al.British Journal of Pharmacology|November 1, 1975
The pharmacokinetics of pyridostigmine and 3-hydroxy-N-methylpyridinium in the rat: dose-dependent effects after portal vein administrationH E Barber, G R Bourne, T N Calvey, et al.Pageof 3